COVID-19 has changed clinical trials forever. To find out how CROs have adapted to the global pandemic and whether this will have a lasting impact ...
.jpg)
With such a strong 2019, 2020 was expected to be a ‘mega year’ for life science companies with a reported $1.4 trillion in firepower at their disposal for M&As. However, COVID-19 gave us an unexpected twist.
COVID-19 has changed clinical trials forever. To find out how CROs have adapted to the global pandemic and whether this will have a lasting impact on the space, I spoke to two industry leaders.
We are undergoing the biggest vaccination program in history, aiming to finally bring the COVID-19 pandemic to an end. This presents pharmacovigilance’s with its biggest test yet.
With such a strong 2019, 2020 was expected to be a ‘mega year’ for life science companies with a reported $1.4 trillion in firepower at their disposal for M&As. However, COVID-19 gave us an unexpected twist.
More and more companies are striving to build diverse and inclusive teams. I wanted to speak to an expert at this, who works within the life sciences arena, to find out what they do.
.jpg)
What does AI mean for drug discovery? This question and many others was answered by three AI experts in our latest CM Life Science webinar.
To gain further insight into how labs have adapted, the CM Life Science team spoke to three North American market leaders in laboratory testing services about how they’ve supported the US healthcare system.
There’s so much potential in analytical instrumentation. After a challenging 2020, next year presents itself as a fresh start for the market and these are the companies that you need to keep an eye on.
For this episode of CM Conversations, our Director of Operations Tom Maskill spoke with QIAGEN CEO Thierry Bernard.
In my line of work you come across new companies everyday, however, few are as forward-thinking and unique as Norman Health. I spoke to the company's founder and Managing Director, Jan-Wilem Eleveld.
For decades, we’ve been talking about how NGS will change the world. But what if NGS was only the start?
Consistent early detection is considered the 'holy grail' of cancer diagnosis. If you can catch cancer early enough, you can stop it developing. Liquid biopsy could be the key to unlocking that potential.
.jpg)
The diagnostics space is doing crucial work to detect and limit the spread of Covid-19 all over the world – with companies both big and small contributing to the cause
Rapid detection for sepsis is crucial. Every hour this disease goes untreated, the chances of mortality go up by 8%. To learn more about the disease, we spoke to the experts.
Prejudice is rife in 2020 (both conscious and unconscious), so it’s crucial that we educate ourselves. It’s never been so important to embrace Black History Month.
.jpg)
The effect of COVID-19 has been huge with thousands of clinical trials interrupted forcing companies and sponsors to adapt. So, they have and the industry may never look the same again.
I spoke to Pierre van Weperen, Managing Director at Grow Biotech UK and Chair of the Board at Dutch National MS Society, about unlocking the true potential of medicinal cannabis.
Animal feed is now responsible for up to 70% of the cost of animal production. To get this figure down and to be more environmentally friendly, the animal market has shifted to sustainable alternatives like additives and different feed sources.
.jpg)
Only 30% of executive positions and 18% of board seats are held by women in biotech. I spoke to industry expert, Melissa Gammell, to find out where we're going wrong, how we get more women into biotech and how we keep them there.
In this episode of CM Conversations, our lab equipment specialist Lucy Smith spoke with Melissa Gammell, Vice President of Business Development at Matphil Technologies about the challenges facing women in biotech.
Animal health is becoming a tough environment for start-ups to compete with major corporations dominating the market share, but all is not lost for these smaller companies.
Cytosurge's tiny syringes are a game changer for the single cell genomic and gene editing applications; since patenting the technology in 2009 the company has gone from strength to strength.
.jpg)
In this episode, our specialist in the lab equipment space, Lucy Smith, spoke with CEO of Elementar Americas Ryan Titmas. Lucy spoke to Ryan about what it takes to get to the top, as well as some of the lessons he’s learned in his career so far.
In this episode, we delved into the Life Science space for a conversation with Mark Rohlfing and Natalie Balanovsky from international pharmaceutical business, Almac.
As businesses prioritise the wellbeing of their employees, the concept of working a 4 day week is shifting from distant pipedream to reality for a range of organisations around the world.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting,
When we talk about genomics hubs, then usually we’d be talking about Oxbridge, Boston or Silicon Valley thanks to success stories like 10x Genomics, Illumina or Solexa. However, as the technology needed to conduct genomic R&D becomes more accessible
In the US alone, a report by the Centers for Disease Control and Prevention (CDC) in March this year highlighted how 2.8 million antibiotic-resistant infections occur each year, leading to the deaths of more than 35,000 people.
Coronavirus has provided us with a very large and extremely recent data set for research, patient populations and how different ethnic minorities are being affected versus the research. And the early indicators are that those from minority background
The approach to fighting coronavirus has not differed to the fight against any other outbreak in terms of what is required to control it.
One of the biggest partnering events in the life science calendar Bio-Europe Spring, was scheduled to take place in Paris from March 23 – 27 this year. That all changed with the emergence of COVID-19...
